About this release
This release by Public Health Scotland provides an annual and quarterly update of immunisation uptake rates for children in Scotland. Immunisation programmes for children aim to protect the individual child from many serious infectious diseases and prevent the spread of disease in the wider population. Information is shown for NHS Boards and local authorities, at 12 months, 24 months, 5 years and 6 years of age.
- Quarterly uptake rates remained high in Scotland; around 96% of children had received each routine immunisation by the time they were 12 months old, with the exception of rotavirus vaccine, which had 94.5% uptake.
*Children turning 12 months of age in the relevant quarter e.g. for Jan-Mar 22 this would be children born during Jan-Mar 21.
- Most children received their booster vaccines by 24 months of age: Hib/MenC (94.7%), Pneumococcal Conjugate Vaccine (PCV) (94.0%) and MenB (94.2%).
- The first dose of MMR vaccine is offered between 12 and 13 months old and the second dose at 3 years 4 months old.
- 94.4% of children had the first dose of MMR vaccine by 24 months of age. This rose to 95.9% for children who had reached age 5.
- Uptake of the second dose of MMR vaccine by 5 years was 91.9%, rising to 93.3% by age 6 years.
As a public health measure, immunisations are very effective in reducing the burden of disease. The European Region of the World Health Organization (WHO) recommends that on a national basis at least 95% of children are immunised against diseases preventable by immunisation and targeted for elimination or control. These include diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), measles, mumps and rubella.
Rotavirus vaccine should be given within strict age limits, with the first dose before 15 weeks and second dose before 24 weeks of age. These age limits mean that if a child is not immunised with the first dose early enough, due to missed appointments for example, then it may not be possible for them to complete the full 2 dose course before 24 weeks. This explains why uptake of the completed 2 dose course of rotavirus vaccine is slightly lower than completed courses of the other vaccines offered in the first year of life.
Information on uptake among pre-school children eligible for immunisation during the coronavirus (COVID-19) pandemic is available on our COVID-19 wider impacts on the healthcare system dashboard and shows that uptake has remained high.
The next release of this publication will be 27 September 2022.
If you have an enquiry relating to this publication, please email firstname.lastname@example.org.
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email email@example.com.
To report any issues with a publication, please email firstname.lastname@example.org.